oleanolic acid has been researched along with Cardiovascular Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, H; Sun, A | 1 |
| Jin, Y; Li, M; Li, X; Zhou, L | 1 |
| Bhindi, R; Birgisdottir, AB; Bubb, KJ; Figtree, GA; Hansen, T; Karimi Galougahi, K; Kok, C; Meyer, C; Rasko, NB; Reisman, SA; Ritchie, R; Tang, O; Ward, K | 1 |
3 other study(ies) available for oleanolic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Novel Findings and Therapeutic Targets in Cardioprotection.
Topics: Aging; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Myocardial Infarction; Oleanolic Acid | 2019 |
Effects of total saponins from Panacis majoris Rhizoma and its degradation products on myocardial ischemia-reperfusion injury in rats.
Topics: Animals; Blood Viscosity; Chromatography, High Pressure Liquid; Ginsenosides; Hemodynamics; Magnetic Resonance Spectroscopy; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oleanolic Acid; Panax; Platelet Aggregation; Rats; Rats, Wistar; Rhizome; Saponins | 2020 |
The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Disease Models, Animal; Fibronectins; Glutaredoxins; Heart; Humans; Male; Myocardial Infarction; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Oleanolic Acid; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Ventricular Remodeling | 2017 |